Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.

MLA

Cohen, Shlomi, et al. “Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-Center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.” Paediatric Drugs, vol. 26, no. 5, Sept. 2024, pp. 609–17. EBSCOhost, https://doi.org/10.1007/s40272-024-00631-z.

APA

Cohen, S., Rolandsdotter, H., Kolho, K.-L., Turner, D., Tzivinikos, C., Bramuzzo, M., Pujol-Muncunill, G., Scarallo, L., Urlep, D., Rinawi, F., Granot, M., Kang, B., Longueville, Y., Rodríguez-Belvís, M. V., Weintraub, Y., Navas-López, V. M., & Yerushalmy-Feler, A. (2024). Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN. Paediatric Drugs, 26(5), 609–617. https://doi.org/10.1007/s40272-024-00631-z

Chicago

Cohen, Shlomi, Helena Rolandsdotter, Kaija-Leena Kolho, Dan Turner, Christos Tzivinikos, Matteo Bramuzzo, Gemma Pujol-Muncunill, et al. 2024. “Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-Center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.” Paediatric Drugs 26 (5): 609–17. doi:10.1007/s40272-024-00631-z.